Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Antianxiety Effects of Fatty Acid Amide Hydrolase Inhibition (full – 2010)
Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders? (full – 2010)
Brain CB2 Receptors: Implications for Neuropsychiatric Disorders (link to PDF– 2010)
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. (abst - 2010)
Cannabinoids and anxiety (abst – 2010)
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice (abst – 2010)
Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: strain differences in drug-induced anxiety (abst – 2010)
Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors (abst – 2010)
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (full – 2011)
Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress (full – 2011)
Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation Paradigm (full – 2011)
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)
Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay (full – 2011)
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients (full – 2011)
Cannabinoids and emotionality: a neuroanatomical perspective (abst – 2011)
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats. (abst – 2011)
Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems (abst – 2011)
Behavioral alterations in cystic fibrosis mice are prevented by cannabinoid treatment in infancy (abst – 2011)
A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats. (abst – 2011)
Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists (abst – 2011)
New Findings on How the Brain’s Own Marijuana-Like Chemicals Suppress Pain (news – 2011)
A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity (full – 2012)
Differences in Spontaneously Avoiding or Approaching Mice Reflect Differences in
CB1-Mediated Signaling of Dorsal Striatal Transmission (full – 2012)
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug (full – 2012)
The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear conditioned analgesia and controls fear expression in the presence of nociceptive tone (full – 2012)
Interleukin-1β causes anxiety by interacting with the endocannabinoid system (full – 2012)
Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives (full – 2012)
Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice (full – 2012)
Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans (full – 2012)
Cannabidiol in humans-the quest for therapeutic targets (full – 2012)
Comparative Study of Sedation, Pre-Anesthetic and Anti-Anxiety Effects of Hemp Seed Extract and Diazepam in Rats (full – 2012)
Opposing Roles for Cannabinoid Receptor Type-1 (CB(1)) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats (full – 2012)
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders (full – 2012)
Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABA(B) Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission (full – 2012)
Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: Effects of the cannabinoid receptor 1 antagonist AM251 (full – 2012)
Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid Receptors (full – 2012)
Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1 (full – 2012)
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full – 2012)
Bidirectional regulation of endocannabinoid signaling in the amygdala contributes to activation and adaptation of the stress response (abst – 2012)
Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test (abst – 2012)
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment (abst – 2012)
Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it (abst – 2012)
Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia (abst – 2012)
Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo (abst – 2012)
Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear. (abst – 2012)
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour (abst – 2012)
Prevalence of Cannabis Use Disorder Diagnoses Among Veterans in 2002, 2008, and 2009 (abst – 2012)
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors (abst – 2012)
Cannabinoid CB(1) receptor in the modulation of stress coping behaviour in mice: the role of serotonin and different forebrain neuronal subpopulations (abst – 2012)
Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists (abst – 2012)
Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats (abst – 2012)
Cannabis Use Vulnerability Among Socially Anxious Users: Cannabis Craving During a Social Interaction (abst – 2012)
CB1 receptor activation in the nucleus accumbens core impairs contextual fear learning (abst – 2012)
Cannabinoid Modulation of Midbrain Urocortin 1 Neurones During Acute and Chronic Stress (abst – 2012)
Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test. (abst – 2012)
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids (abst - 2012)
Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test. (abst – 2012)
Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin? (abst – 2012)
Brain altering drug calms fears also (news – 2012)
Effect of dietary fat type on anxiety-like and depression-like behavior in mice (full – 2013)
Endocannabinoid system and mood disorders: Priming a target for new therapies (full – 2013)
Translational evidence for the involvement of the endocannabinoid system in stress related psychiatric illnesses (full – 2013)
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report (full – 2013)
Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors. (full– 2013)
Voluntary Running in Young Adult Mice Reduces Anxiety-Like Behavior and Increases the Accumulation of Bioactive Lipids in the Cerebral Cortex (full – 2013)
Cannabinoid facilitation of fear extinction memory recall in humans (full– 2013)
Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade (full – 2013)
Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link? (full – 2013)
Does Cannabidiol Protect Against Adverse Psychological Effects of THC? (full – 2013)
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation (full – 2013)
Dissociation of the Pharmacological Effects of THC by mTOR Blockade (full – 2013)
The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD) (full – 2013)
Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms (abst – 2013)
Cannabidiol enhances consolidation of explicit fear extinction in humans (abst – 2013)
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system (abst – 2013)
Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice. (abst – 2013)
Neonatal lipopolysaccharide treatment has long term effects on monoaminergic and cannabinoid receptors in the rat (abst – 2013)
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats (abst – 2013)
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability (abst – 2013)
Role of TRPV1 receptors on panic-like behaviors mediated by the dorsolateral periaqueductal gray in rats (abst – 2013)
Involvement of prelimbic medial prefrontal cortex in panic-like elaborated defensive behaviour and innate fear-induced antinociception elicited by GABAA receptor blockade in the dorsomedial and ventromedial hypothalamic nuclei: role of the endocannabinoid CB1 receptor. (abst – 2013)
Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats (abst – 2013)
CB1 receptor signaling regulates social anxiety and memory (abst – 2013)
Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat (abst – 2013)
Cannabidiol attenuates the long lasting cognitive deficits and anxiogenic-like behaviors promoted by murine cerebral malaria (abst – 2013) -971c-4daa-8b8c-38c0c63c19ad
Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activity in the elevated T-maze (abst – 2013)
Modulation of anxiety-like behaviour by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray. (abst – 2013)
The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats (abst – 2013)
Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdale. (abst – 2013)
Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression (abst – 2013)
Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats. (abst – 2013)
Continuous central infusion of cannabinoid receptor agonist WIN 55,212-2 decreases maternal care in lactating rats: Consequences for fear conditioning in adulthood males (abst – 2013)
The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae) (abst – 2013)
Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience (abst – 2013)
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders (abst – 2013)
Cannabis use motives and personality risk factors (abst – 2013)
The endocannabinoid system: An emotional buffer in the modulation of memory function (abst – 2013)
Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments (abst – 2013)
Potential new way to treat anxiety (news – 2013)
Terpenes May Improve Effectiveness Of Medical Marijuana (news – 2013)
Therapeutic benefits of cannabis: a patient survey. (full – 2014)
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full – 2014)
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation (full – 2014)
How Cannabis Causes Paranoia: Using the Intravenous Administration of ∆9-Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia (full – 2014) http://schizophreniabulletin.oxfordj...ul.sbu098.long
Genetic Disruption of 2-Arachidonoylglycerol Synthesis Reveals a Key Role for Endocannabinoid Signaling in Anxiety Modulation. (full – 2014)
Cannabis use and anxiety: is stress the missing piece of the puzzle? (full – 2014)
Cannabinoid modulation of predator fear: involvement of the dorsolateral periaqueductal gray. (abst – 2014)
Impaired Fear Memory Specificity Associated with Deficient Endocannabinoid Dependent Long-Term Plasticity (abst – 2014)
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors (abst – 2014)
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. (abst – 2014)
Stress regulates endocannabinoid-CB1 receptor signaling. (abst – 2014)
β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. (abst – 2014)
Inhibition of FAAH enzyme by pterostilbene: potential mechanism of anxiolytic action (abst – 2014)
Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain. (abst – 2014)
Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies. (abst – 2014)
Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs (abst – 2014)
Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat (abst – 2014)
Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats (abst – 2014)
Anxiogenic-like effects induced by hemopressin in rats (abst – 2014)
DiffereTranslational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder (abst – 2014)
Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease. (abst – 2014)
Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases. (abst - 2014)
Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat. (abst - 2014)
Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation (abst – 2014)
Mouse Study Sheds Light on Pot’s Anxiety Relief (news – 2014)
Marijuana's anxiety relief effects: Receptors found in emotional hub of brain (news – 2014)
How Black Pepper relieves Cannabis Anxiety (news – 2014)
The surprising everyday ingredient that can reduce pot paranoia (news – 2014)
Activating cannabinoid brain receptors could replace marijuana for anxiety treatment (news – 2014)
Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity (full – 2015)
Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence (abst – 2015)
Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses (abst – 2015)
Increased contextual fear conditioning in iNOS knockout mice: additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system (abst – 2015)
Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression (abst – 2015)
Central administration of GPR55 receptor agonist and antagonist modulates anxiety related behaviors in rats (abst – 2015)